Coucil On Radionuclides And Radiopharmaceuticals Inc

Learn about this cause: Is it Legit? Do I like the mission? What is the CEO's salary?

EIN: 680299230 ✦ Washington, DC ✦ Designated as a 501(c)(6)

Shop smarter and support your favorite cause at the same time! With the Give Freely browser extension, you'll automatically save money with coupons, and partner stores will donate to your chosen charity - at no extra cost to you. Start giving back with a single click. It's safe, free, and spam-free, guaranteed!

Overview

What is Coucil On Radionuclides And Radiopharmaceuticals Inc?

Coucil on Radionuclides and Radiopharmaceuticals Inc, based in Washington D.C., serves as an advocacy group for the radiopharmaceuticals industry in North America. Their mission is to proactively engage in regulatory and legislative processes at various government levels, ensuring reasonable controls for the development, manufacturing, transportation, usage, service, and disposal of radioactive products used in medicine and life sciences. Additionally, they actively promote public awareness of the benefits derived from such products and services, contributing positively to healthcare, transportation safety, homeland security, and manufacturing sectors.


Official website here: www.corar.org

Is Coucil On Radionuclides And Radiopharmaceuticals Inc legitimate?

Coucil On Radionuclides And Radiopharmaceuticals Inc is a legitimate nonprofit organization registered as a 501(c)(6) entity. Coucil On Radionuclides And Radiopharmaceuticals Inc submitted a form 990, which is a tax form used by tax-exempt organizations in the U.S., indicating its operational transparency and adherence to regulatory requirements. Donations to this organization are tax deductible.


Heare are some key statistics you may want to consider:

Executive Compensation: $240,480
Professional Fundraising Fees: $0
Other Salaries and Wages: $0

For more financial information, click here


Official website here: www.corar.org

What is the mission statement of Coucil On Radionuclides And Radiopharmaceuticals Inc?

The Council on Radionuclides and Radiopharmaceuticals Inc. serves as the advocacy group for the radionuclides and radiopharmaceuticals industry in North America. Its mission is to advocate for policies that positively impact healthcare, transportation safety, homeland security, and manufacturing, with the ultimate goal of expanding access to safe and affordable healthcare treatments using radioactive products. The council actively monitors and assists in regulatory and legislative processes at all government levels, ensuring reasonable regulations and legislation on the development, manufacturing, transportation, use, service, and disposal of radioactive products in medicine and the life sciences. Furthermore, the council promotes public awareness of the benefits of these products and services to legislators and regulators.


Official website here: www.corar.org

Who is the CEO of Coucil On Radionuclides And Radiopharmaceuticals Inc?

Ira Goldman is the Chairman of Coucil On Radionuclides And Radiopharmaceuticals Inc.


Official website here: www.corar.org

What is the revenue of Coucil On Radionuclides And Radiopharmaceuticals Inc?

Coucil On Radionuclides And Radiopharmaceuticals Inc's revenue in 2022 was $899,428.


Official website here: www.corar.org

Who are the executives of Coucil On Radionuclides And Radiopharmaceuticals Inc and what are their salaries?

There 20 volunteers at Coucil On Radionuclides And Radiopharmaceuticals Inc.


Here are 18 key members and their salaries:


Steve Laflin (Chairman)
  • Compensation: $0
  • Related: $0
  • Other: $0
Alexandre Gibim (Director)
  • Compensation: $0
  • Related: $0
  • Other: $0
Shaemus Gleason (Director)
  • Compensation: $0
  • Related: $0
  • Other: $0
Roy Brown (Director)
  • Compensation: $0
  • Related: $0
  • Other: $0
Michael Pintek (Director)
  • Compensation: $0
  • Related: $0
  • Other: $0
Jim Wilson (Director)
  • Compensation: $0
  • Related: $0
  • Other: $0
Chris Wagner (Director)
  • Compensation: $0
  • Related: $0
  • Other: $0
Jay Simon (Director)
  • Compensation: $0
  • Related: $0
  • Other: $0
Sergio Calvo (Director)
  • Compensation: $0
  • Related: $0
  • Other: $0
Mike Rosol (Director)
  • Compensation: $0
  • Related: $0
  • Other: $0
James Harvey (Director)
  • Compensation: $0
  • Related: $0
  • Other: $0
Paul Blanchfield (Director)
  • Compensation: $0
  • Related: $0
  • Other: $0
David Robertson (Director)
  • Compensation: $0
  • Related: $0
  • Other: $0
Eric Schutt (Director)
  • Compensation: $0
  • Related: $0
  • Other: $0
Campbelle Mongilia (Director)
  • Compensation: $0
  • Related: $0
  • Other: $0
David Pellicciarini (Vice Chairman)
  • Compensation: $0
  • Related: $0
  • Other: $0
Ira Goldman (Secretary/Treasurer)
  • Compensation: $0
  • Related: $0
  • Other: $0
Michael Guastella (Executive Director)
  • Compensation: $240,480
  • Related: $0
  • Other: $0


Official website here: www.corar.org

Where can I find the form 990 for Coucil On Radionuclides And Radiopharmaceuticals Inc?

Coucil On Radionuclides And Radiopharmaceuticals Inc's most recent form 990 was submitted in 2022 and can be accessed here.


Official website here: www.corar.org

Learn more at the official website: www.corar.org

Mission Statement of Coucil On Radionuclides And Radiopharmaceuticals Inc

Council on Radionuclides and Radiopharmaceuticals Inc serves as an advocacy group, actively participating in regulatory and legislative processes at various government levels. Their primary objective is to ensure reasonable controls on the development, manufacturing, transportation, use, service, and disposal of radioactive products used in medicine and the life sciences. By doing so, they aim to expand access to safe and affordable healthcare treatments for all.

Furthermore, Council on Radionuclides and Radiopharmaceuticals Inc acts as the trade association and voice for the radionuclides and radiopharmaceuticals industry in North America. They advocate for public policies that impact healthcare, transportation safety, homeland security, and manufacturing. This proactive approach aims to create a favorable environment for the industry, ensuring the continued provision of these essential medical treatments. By promoting public awareness of the benefits of these products and services, they contribute to societal well-being.

Shop smarter and support your favorite cause with the Give Freely browser extension. Save money with coupons and donate to charity with a single click. Download now!

Impact




October, 2024

The Council On Radionuclides And Radiopharmaceuticals Inc (CORAR) significantly influences the regulatory landscape surrounding radioactive products utilized in healthcare and life sciences. By actively monitoring and representing the interests of the radionuclides and radiopharmaceuticals industry, CORAR plays a critical role in engaging with policymakers at all levels of government. This advocacy ensures that regulations governing the development, manufacture, transportation, use, service, and disposal of radioactive products are reasonable and balanced, promoting both safety and innovation.

CORAR also emphasizes the importance of public awareness regarding the benefits of radioactive products and services. Through education and engagement with legislators and regulators, they work to dispel misconceptions and highlight how these products contribute to advancements in medical treatments and healthcare solutions. This commitment not only enhances public understanding but also fosters an environment conducive to the responsible growth of the industry.

By championing public policies that affect healthcare access, transportation safety, and manufacturing practices, CORAR is dedicated to expanding access to safe and effective healthcare treatments for all, thereby making a positive impact on the community and society at large. Their efforts ensure that the radionuclides and radiopharmaceuticals industry remains a vital component of modern healthcare, ultimately benefiting patients and the broader health ecosystem.




This information is meant to be a general summary of Coucil On Radionuclides And Radiopharmaceuticals Inc. Please take the time to review official sources before making any decisions based upon the content provided here.


Financials

This financial information is from Propublica.

Revenue
$899,428 (2022)
Expenses
$875,782 (2022)
Efficiency

Other financial information:

This information is from the most recently submitted tax form from this organization, which was in 2022.

  • Investment Income: $5,356
  • Program Service Revenue: $894,072
  • Gross Receipts: $899,428

Assets and Liabilities:

  • Total Assets: $1,555,856
  • Total Liabilities: $270,575
  • Net Assets: $1,285,281

Want to help this charity, for free? You can click here to learn more about Give Freely

Programs

Programs are reported by nonprofits in their tax forms and are normally their tax-exempt activities.

MEMBERSHIP DUES

Revenue

$879,072

SIC REVENUE

Revenue

$15,000

Organization Details

Founding Year

1993

Principal Officer

Ira Goldman

Main Address

500 NORTH CAPITOL STREET NW 210, WASHINGTON, DC, 200017407

NTEE Category

Code: S41 - Community improvement

If you are a representative of Coucil On Radionuclides And Radiopharmaceuticals Inc and wish to learn more about how Give Freely can help you raise funds, please click here: https://givefreely.com/nonprofits/. Our services are offered at no cost to your organization.